Key Publications December 12, 2022

Apolipoprotein B, residual cardiovascular risk after acute coronary syndrome, and effects of alirocumab.

Circulation. 2022;146:657-672

Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators